Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.31 | N/A |
| PEG Ratio (TTM) | -0.03 | N/A |
| P/S Ratio (TTM) | 0.19 | N/A |
| P/B Ratio (TTM) | 0.66 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | -1.52 | N/A |
| Price to 5YR AVG FCF Ratio | -14.56 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -79.61% | N/A |
| ROE (TTM) | -229.83% | N/A |
| Net Profit Margin (TTM) | -53.54% | N/A |
| ROIC 5YR AVG | -16.03% | N/A |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -43,511.53% | -117.36% | -195.04% |
| Revenue | 8.08% | 22.27% | 15.76% |
| Net Income | -45,595.59% | -149.69% | -235.56% |
| Cash Flow | 12.91% | -161.80% | -87.39% |
Health (25%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.55 | N/A |
| Quick Ratio (TTM) | 1.22 | N/A |
| D/E Ratio (TTM) | 0.92 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -5.73 | N/A |
| Shares Outstanding Growth 5YR AVG | 19.01% | N/A |